(Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1517.)
© 1998 American Heart Association, Inc.
Jeffrey M. Hoeg
Dr Jeffrey M. Hoeg died July 21,
1998, following a short, courageous battle with renal
cancer. Jeff's death at the young age of 46 was a terrible loss
to his colleagues and to the fields of hyperlipidemia and
cardiovascular disease. Jeff was a remarkable physician-scientist with
a charismatic personality, an infectious smile, and a wonderful sense
of humor. He thoroughly enjoyed life and was a joy to be around. Each
of us benefited from Jeff's warmth, enthusiasm, and positive
attitude. Jeff was a superb role model, both as a physician-scientist
and mentor, as well as a friend of young investigators.
He guided each young scientist with great care and
insight as their careers blossomed under his tutelage. In addition to
being an outstanding investigator, Jeff was an excellent physician and
was loved by his patients. He had a particular interest in children
with familial hypercholesterolemia and played a central role in the
development of new and innovative treatment programs for these patients
with very high cholesterol levels. Jeff was internationally known for
the treatment of familial hypercholesterolemia and patients were
referred to his care from around the world.
Jeff made several significant contributions to both basic and clinical
research in the fields of lipoproteins and cardiovascular disease. Of
particular importance was the challenging development of transgenic
rabbits as a model system for the study of lipoprotein metabolism and
atherosclerosis. The generation of the transgenic rabbit as a useful
animal model is Jeff's legacy to the field of cardiovascular
disease.
Jeff . . . [Full Text of this Article]